Alvotech trades on the Nasdaq Stock Market

Alvogen, Alvotech and Róbert Wessman and his family support UNICEF

Alvotech Resolves U.S. Patent and Trade Secret Disputes with AbbVie, Securing U.S. Rights for Alvotech’s Proposed High-Concentration Biosimilar (AVT02) for Humira.

Create a global pharmaceutical powerhouse

Róbert Wessman-led Aztiq and Innobic join forces in US $475m acquisition of Lotus and Adalvo

New office for the Private Equity Fund Aztiq

Róbert Wessman Inaugurates New London Offices

Continuing the momentum started and consolidate its foothold in France

Maison Wessman buys the Vignoble des Verdots: continuing the momentum started and consolidate its foothold in France

Róbert Wessman's Maison Wessman buys the Vignoble des Verdots

USD $100 million financing to purchase newly issued share equity in Alvogen US.

Alvotech Reaches Primary Completion Date in Its Switching Study for AVT02, a Proposed Interchangeable Biosimilar to AbbVie’s Humira® 

A key milestone in Alvotech's program for AVT02

I get inspired by the great people I surround myself with every day; people I know well and those I am seeing for the first time whom I don’t know at all.

Róbert Wessman - Alvotech’s New Biosimilar Drug

Róbert Wessman - Alvotech doubles the size of high-tech facilities

Alvotech doubles the size of high-tech facilities

Anil Okay – General Manager, Adalvo & Chief Commercial Officer, Alvotech

Partnerships provide global foundation for Alvotech

Stories

Stories

Róbert Wessman becomes CEO of Alvotech

Lotus reports its best quarter ever

"Day we will never forget" - Video

Alvogen, Alvotech and Róbert Wessman and his family support UNICEF

"A Key Milestone for patients"

Róbert Wessman-led Aztiq and Innobic join forces in US $475m acquisition of Lotus and Adalvo

New London office

Róbert Wessman's Maison Wessman buys the Vignoble des Verdots

Aztiq buys 17% stake in Alvogen US

A key milestone in Alvotech's program

Alvotech employees donate to UNICEF

Alvotech fundraising for UNICEF

Why I Don't Have A Role Model

Women Power

Alvotech’s New Biosimilar Drug

Alvotech doubles the size of high-tech facilities

Alvo Global kick off meeting

Róbert Wessman discusses Alvotech

Anil Okay on Alvotech’s strategy

Partnerships provide global foundation for Alvotech